MoneyWorks4Me

Mankind Pharma - Quaterly Results

31 Jul 2024 Evaluate
The company witnessed a 14.86% growth in the revenue at Rs. 24032.60 millions for the quarter ended June 2024 as compared to Rs. 20922.80 millions during the year-ago period.An average growth of 27.51% was recorded for the quarter ended June 2024 to Rs. 4842.50  millions from Rs. 3797.80 millions.Operating profit surged to 6670.30 millions from the corresponding previous quarter of 5554.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 24032.60 20922.80 14.86 24032.60 20922.80 14.86 92648.09 81271.53 14.00
Other Income 948.30 574.40 65.09 948.30 574.40 65.09 2666.38 1627.83 63.80
PBIDT 6670.30 5554.00 20.10 6670.30 5554.00 20.10 25917.44 18601.65 39.33
Interest 62.60 19.70 217.77 62.60 19.70 217.77 145.70 277.48 -47.49
PBDT 6607.70 5534.30 19.40 6607.70 5534.30 19.40 25771.74 18324.17 40.64
Depreciation 834.00 685.10 21.73 834.00 685.10 21.73 3176.06 2695.80 17.82
PBT 5773.70 4849.20 19.07 5773.70 4849.20 19.07 22595.68 15628.37 44.58
TAX 931.20 1051.40 -11.43 931.20 1051.40 -11.43 4361.57 3145.79 38.65
Deferred Tax -152.20 137.80 -210.45 -152.20 137.80 -210.45 195.98 229.43 -14.58
PAT 4842.50 3797.80 27.51 4842.50 3797.80 27.51 18234.11 12482.58 46.08
Equity 400.59 400.59 0.00 400.59 400.59 0.00 400.59 400.59 0.00
PBIDTM(%) 27.76 26.55 4.56 27.76 26.55 4.56 27.97 22.89 22.22
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..